Skip to main content

Advertisement

SpringerLink
Log in

Is it safe to perform completion lobectomy after diagnostic wedge resection using video-assisted thoracoscopic surgery?

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

The objective of this study was to assess the safety of video-assisted thoracoscopic surgery (VATS) completion lobectomy (CL) for non-small cell lung cancer (NSCLC) after diagnostic wedge resection by comparing with standard VATS lobectomy (SL).

Methods

Data were retrieved from an institutional database of consecutive VATS lobectomies between January 1st 2007 and December 31st 2013. Patients were grouped into CL or SL. Patient characteristics, operative data, converted procedures, complications, and mortality was compared using Pearson Chi square, Fisher’s exact test, or Mann–Whitney U test.

Results

In total 80 CL and 958 SLs were performed. There were no significant differences in median operating time, median chest drain duration or median length of stay. Median operative bleeding was 100 mL (IQR 50–238) in the CL group compared to 75 mL (IQR 25–200) in the SL group (p = 0.01). There were no differences between groups in major or minor complications. Median time from VATS wedge resection to CL was 33 days (IQR 27–41). Conversion rate was 1.3 % in the CL group and 2.6 % in the SL group (p = 0.72). 30-day mortality was 0 vs. 1.1 % for the CL group and the SL group accordingly (p > 0.99).

Conclusions

This study comparing short-term surgical outcome and complications after surgical treatment of NSCLC indicates that VATS completion lobectomy after diagnostic wedge resection seems safe when looking at a relatively short time interval between the two procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Notes

  1. The Capital Region and Region Zealand are two regions of total five in Denmark. Population: approximately 2.6 million.

References

  1. McKenna RJ Jr. Surgical management of primary lung cancer. Semin Oncol. 2007;34:250–5.

    Article  PubMed  Google Scholar 

  2. Wolf AS, Richards WG, Jaklitsch MT, Gill R, Chirieac LR, Colson YL, et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg. 2011;92:1819–23.

    Article  PubMed  Google Scholar 

  3. Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive summary: diagnosis and management of lung cancer, 3rd ed: american College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:7S–37S.

    Article  CAS  PubMed  Google Scholar 

  4. Pan X, Fu S, Shi J, Yang J, Zhao H. The early and long-term outcomes of completion pneumonectomy: report of 56 cases. Interact CardioVasc Thorac Surg. 2014;19:436–40.

    Article  PubMed  Google Scholar 

  5. Tabutin M, Couraud S, Guibert B, Mulsant P, Souquet PJ, Tronc F. Completion pneumonectomy in patients with cancer: postoperative survival and mortality factors. J Thorac Oncol. 2012;7:1556–62.

    Article  PubMed  Google Scholar 

  6. Nomori H, Mori T, Izumi Y, Kohno M, Yoshimoto K, Suzuki M. Is completion lobectomy merited for unanticipated nodal metastases after radical segmentectomy for cT1 N0 M0/pN1-2 non-small cell lung cancer? J Thorac Cardiovasc Surg. 2012;143:820–4.

    Article  PubMed  Google Scholar 

  7. Byers TE, Vena JE, Rzepka TF. Predilection of lung cancer for the upper lobes: an epidemiologic inquiry. J Natl Cancer Inst. 1984;72:1271–5.

    CAS  PubMed  Google Scholar 

  8. Kinsey CM, Estepar RS, Zhao Y, Yu X, Diao N, Heist RS, et al. Invasive adenocarcinoma of the lung is associated with the upper lung regions. Lung Cancer. 2014;84:145–50.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Petersen RH, Hansen HJ. Learning thoracoscopic lobectomy. Eur J Cardiothorac Surg. 2010;37:516–20.

    Article  PubMed  Google Scholar 

  10. Hansen HJ, Petersen RH, Christensen M. Video-assisted thoracoscopic surgery (VATS) lobectomy using a standardized anterior approach. Surg Endosc. 2011;25:1263–9.

    Article  PubMed  Google Scholar 

  11. McElnay P, Casali G, Batchelor T, West D. Adopting a standardized anterior approach significantly increases video-assisted thoracoscopic surgery lobectomy rates. Eur J Cardiothorac Surg. 2014;46:100–5.

    Article  PubMed  Google Scholar 

  12. Berry MF, D’Amico TA, Onaitis MW, Kelsey CR. Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. Ann Thorac Surg. 2014;98:197–202.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Falcoz PE, Puyraveau M, Thomas PA, Decaluwe H, Hurtgen M, Petersen RH, et al. Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg. 2016;49:602–9.

    Article  PubMed  Google Scholar 

  14. Laursen LO, Petersen RH, Hansen HJ, Jensen TK, Ravn J, Konge L. Video-assisted thoracoscopic surgery lobectomy for lung cancer is associated with a lower 30-day morbidity compared with lobectomy by thoracotomy. Eur J Cardiothorac Surg. 2016;49:870–5.

    Article  PubMed  Google Scholar 

  15. Taioli E, Lee DS, Lesser M, Flores R. Long-term survival in video-assisted thoracoscopic lobectomy vs open lobectomy in lung-cancer patients: a meta-analysis. Eur J Cardiothorac Surg. 2013;44:591–7.

    Article  PubMed  Google Scholar 

  16. Yan TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol. 2009;27:2553–62.

    Article  PubMed  Google Scholar 

  17. Bender MT, Ferraris VA, Saha SP. Modern management of thoracic empyema. South Med J. 2015;108:58–62.

    Article  PubMed  Google Scholar 

  18. Kara HV, Balderson SS, D’Amico TA. Challenging cases: thoracoscopic lobectomy with chest wall resection and sleeve lobectomy-Duke experience. J Thorac Dis. 2014;6:S637–40.

    PubMed  PubMed Central  Google Scholar 

  19. Kato M, Onishi H, Furugaki K, Yunotani S, Matsumoto K, Tsuruta N, et al. New approach to complete video-assisted thoracoscopic lobectomy in T2 and T3 non-small cell lung cancer. Anticancer Res. 2015;35:3585–9.

    PubMed  Google Scholar 

  20. Pischik VG. Technical difficulties and extending the indications for VATS lobectomy. J Thorac Dis. 2014;6:S623–30.

    PubMed  PubMed Central  Google Scholar 

  21. Hanna JM, Berry MF, D’Amico TA. Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open. J Thorac Dis. 2013;5:182–9.

    Google Scholar 

Download references

Acknowledgments

The authors wish to thank Lykke Østergaard Laursen for her contribution to statistical calculations.

Author information

Authors and Affiliations

  1. Department of Cardiothoracic Surgery, RT-2152, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark

    Bo Laksáfoss Holbek, René Horsleben Petersen & Henrik Jessen Hansen

  2. Section for Surgical Pathophysiology, JMC-7621, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark

    Bo Laksáfoss Holbek

Authors
  1. Bo Laksáfoss Holbek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. René Horsleben Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henrik Jessen Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bo Laksáfoss Holbek.

Ethics declarations

Conflict of interest

Dr. René Horsleben Petersen is speaker for Covidien, Medela and Takeda and Dr. Henrik Jessen Hansen is speaker for Covidien, Medela and Bard. Dr. Bo Laksáfoss Holbek received a research grant from Dr. Fritz Karner and wife Edith Karner Foundation for promoting and optimizing the perioperative patient trajectory.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holbek, B.L., Petersen, R.H. & Hansen, H.J. Is it safe to perform completion lobectomy after diagnostic wedge resection using video-assisted thoracoscopic surgery?. Gen Thorac Cardiovasc Surg 64, 203–208 (2016). https://doi.org/10.1007/s11748-016-0633-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-016-0633-4

Keywords

Search

Navigation